Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Arctic LNG 2 project helped by China

2/21/24 NVTK

Mosgorlombard may conduct a buyback

2/21/24 MGKL

Bank of Russia established the fact of manipulation of SPB Exchange shares

2/21/24 SPBE

Mechel reported for 2023 by IFRS

2/21/24 MTLR

Mechel reported lower performance in 2023

2/21/24 MTLR

European Electrotechnics reported for 2023 by RAS

2/21/24 EELT

Samolet has entered the software market for developers

2/21/24 SMLT

Ozon will increase the number of fashion retailers by 1.5 times

2/21/24 OZON

PhosAgro increased supplies to the domestic market

2/21/24 PHOR

The Central Bank revoked the license of Qiwi Bank

2/21/24 QIWI